Shanu Modi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Positive Breast Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Brain Metastases

Top Venues

Nature reviews. Clinical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology 21 (3) (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology 21 (3) (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology (2024)
Antonio Marra, Sarat Chandarlapaty, Shanu Modi
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. Nature reviews. Clinical oncology 21 (3) (2024)
Guy Jerusalem, Yeon Hee Park, Sara Alsterlind Hurvitz, Shanu Modi, Fabrice Andre, Ian E Krop, Xavier Gonzalez, Benoit You, Cristina Saura, Sung-Bae Kim, Cynthia R Osborne, Rashmi K Murthy, Lorenzo Gianni, Toshimi Takano, Yali Liu, Jillian Cathcart, Caleb Lee, Christophe Perrin
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis. Cancer discovery 12 (12) (2022)
Nelson S Moss, Umberto Tosi, Bianca D Santomasso, Kathryn Beal, Shanu Modi
Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan. CNS oncology 11 (3) (2022)
Prasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, Stephen B Solomon, Valerie W Rusch, Roisin E O'Cearbhaill, Amy Zhu, Waseem Cheema, Navin K Chintala, Elizabeth Halton, John Pineda, Rocio Perez-Johnston, Kay See Tan, Bobby Daly, Jose A Araujo Filho, Daniel Ngai, Erin McGee, Alain Vincent, Claudia Diamonte, Jennifer L Sauter, Shanu Modi, Devanjan Sikder, Brigitte Senechal, Xiuyan Wang, William D Travis, Mithat Gönen, Charles M Rudin, Renier J Brentjens, David R Jones, Michel Sadelain
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab. Cancer discovery 11 (11) (2021)
Komal Jhaveri, Joshua Z Drago, Payal Deepak Shah, Rui Wang, Fresia Pareja, Fanni Ratzon, Alexia Iasonos, Sujata Patil, Neal X Rosen, Monica N Fornier, Nancy T Sklarin, Sarat Chandarlapaty, Shanu Modi
A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Aditya Bardia, Shanu Modi, Mafalda Oliveira, Javier Cortes, Mario Campone, Brigette Ma, Luc Dirix, Amy Weise, Becker Hewes, Ivan Diaz-Padilla, Yu Han, Priya Deshpande, Tanay S Samant, Karen Rodriguez Lorenc, Wei He, Fei Su, Mariana Chavez-MacGregor
Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2- Advanced Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Mark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri, Larry Norton, Bradley J Beattie, Pat B Zanzonico, Danuta Zatorska, Tony Taldone, Stefan O Ochiana, Mohammad M Uddin, Eva M Burnazi, Serge K Lyashchenko, Clifford A Hudis, Jacqueline Bromberg, Heiko M Schöder, Josef J Fox, Hanwen Zhang, Gabriela Chiosis, Jason S Lewis, Steven M Larson
First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Sara M Tolaney, Khanh T Do, Joseph P Eder, Patricia M LoRusso, Colin D Weekes, Sarat Chandarlapaty, Ching-Wei Chang, Shang-Chiung Chen, Denise Nazzal, Eva Schuth, Flavia Brunstein, Montserrat Carrasco-Triguero, Walter C Darbonne, Jennifer M Giltnane, William M Flanagan, S Renee Commerford, Alexander Ungewickell, Geoffrey I Shapiro, Shanu Modi
A Phase I Study of DLYE5953A, an Anti-LY6E Antibody Covalently Linked to Monomethyl Auristatin E, in Patients with Refractory Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (21) (2020)
Karen A Autio, Christopher A Klebanoff, David Schaer, John Sae Wook Kauh, Susan F Slovin, Matthew J Adamow, Victoria S Blinder, Manisha Brahmachary, Michelle Carlsen, Elizabeth Comen, Daniel C Danila, Thompson N Doman, Jeremy C Durack, Josef J Fox, Jill S Gluskin, David M Hoffman, Suhyun Kang, Praneet Kang, Jonathan Landa, Philomena F McAndrew, Shanu Modi, Michael J Morris, Ruslan Novosiadly, Dana E Rathkopf, Rachel Sanford, Sonya C Chapman, Courtney M Tate, Danni Yu, Phillip Wong, Heather L McArthur
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (21) (2020)